Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

OMass Therapeutics

OMass Therapeutics
2016 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$18.1M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of a structural mass spectrometry technology platform intended to provide a new perspective in drug discovery. The company's platform offers access to native mass spectrometry without having to establish sophisticated instrumentation and expertise in-house, as well as provides a way to study complex protein assemblies and their interactions with other biological molecules, enabling biotechnology and pharmaceutical clients to tackle challenging drug targets and biotherapeutics, within a dynamic and collaborative framework.

Website
Formerly Known As
OMass Technologies
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Discovery Tools (Healthcare)
Primary Office
  • The Schrödinger Building
  • Heatley Road, The Oxford Science Park
  • Oxford OX4 4GE
  • England, United Kingdom

+44 01865 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore OMass Therapeutics’s full profile, request a free trial.

OMass Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 21-Nov-2018 $18.1M 000.00 Completed Generating Revenue
1. Early Stage VC 29-Mar-2016 00.000 00.000 00.000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

OMass Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

OMass Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Syncona Venture Capital Minority 000 0000 000000 0
Oxford Sciences Innovation Venture Capital Minority 000 0000 000000 0
Oxford Spin-out Equity Management Venture Capital Minority 000 0000 000000 0

OMass Therapeutics Executive Team (8)

Name Title Board
Seat
Contact
Info
Jonathan Hopper Ph.D Co-Founder & Chief Executive Officer
Idlir Liko Co-Founder & Chief Technology Officer
Ali Jazayeri Ph.D Chief Scientific Officer
Hsin-Yung Yen Chief Scientific Officer
Dame Robinson Co-Founder, Board Member and Chief Scientific Adviosr
You’re viewing 5 of 8 executives. Get the full list »

OMass Therapeutics Board Members (7)

Name Representing Role Since Contact
Info
Dame Robinson OMass Therapeutics Co-Founder, Board Member and Chief Scientific Adviosr 000 0000
David Brister Self Co-Chairman 000 0000
Edward Hodgkin Ph.D Self Co-Chairman 000 0000
Lachlan Mackinnon Oxford Sciences Innovation Board Member 000 0000
Magdalena Jonikas Ph.D Syncona Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »